CD8A and neoplasm: Notably, we detected a significant expansion of dominant antigen-specific CD8+ T cells in both the tumor-draining lymph node (tdLN) as well as the spleens of mice after YUMM-GFP33/66 challenge (SI Appendix, Fig. S2A).